Financial Burden of Lymphedema Hospitalizations in the United States

Mya L Roberson; Paula D Strassle; Luther-King Okunade Fasehun; Daniel O Erim; E Gene Deune; Adeyemi A Ogunleye

doi:10.1001/jamaoncol.2020.7891

Financial Burden of Lymphedema Hospitalizations in the United States

JAMA Oncol. 2021 Apr 1;7(4):630-632. doi: 10.1001/jamaoncol.2020.7891.

Authors

Mya L Roberson¹, Paula D Strassle², Luther-King Okunade Fasehun³, Daniel O Erim⁴, E Gene Deune⁵, Adeyemi A Ogunleye⁵

Affiliations

¹ Department of Epidemiology, UNC Gillings School of Global Public Health, University of North Carolina at Chapel Hill.
² Department of Surgery, School of Medicine, University of North Carolina at Chapel Hill.
³ Department of Epidemiology and Biostatistics, Temple University College of Public Health, Philadelphia, Pennsylvania.
⁴ Advanced Analytics Business Unit, Parexel International Corporation, Durham, North Carolina.
⁵ Division of Plastic Surgery, School of Medicine, University of North Carolina at Chapel Hill.

Abstract

This cohort study uses data from the Healthcare Cost and Utilization Project Inpatient Sample to identify factors associated with high costs incurred during lymphedema-related hospitalizations in adults.

MeSH terms

Cost of Illness
Financial Stress*
Hospitalization
Humans
Lymphedema* / epidemiology
Lymphedema* / therapy
United States / epidemiology